Immuno-oncologic profiling of renal masses using multiparametric MRI: a pilot study
In this pilot study, mpMRI was sensitive to immuno-oncologic biomarkers supporting preoperative MRI as a method of characterizing tumor immune microenvironment, malignancy, and subtype for informed and tailored treatment management.
Authors
- Octavia Bane (ORCID: https://orcid.org/0000-0003-1315-5848)
- Sara Lewis
- Mira Liu (ORCID: https://orcid.org/0000-0002-8729-9302)
- Tin Htwe Thin (ORCID: https://orcid.org/0000-0002-7891-1459)
- Ghadi Abboud
- Arthi Reddy
- Bachir Taouli
- Kirolos Meilika (ORCID: https://orcid.org/0000-0003-1375-8059)
- Laura Zuluaga (ORCID: https://orcid.org/0000-0002-2612-6950)
- Xin Mu
- Bernd Kühn (ORCID: https://orcid.org/0000-0002-6852-2433)
- Monica Garcia-Barros
- Haitham Al-Mubarak (ORCID: https://orcid.org/0000-0002-7273-5415)
- Amir Horowitz (ORCID: https://orcid.org/0000-0003-4602-1440)
- Rachel Brody (ORCID: https://orcid.org/0000-0001-9280-517X)
- Philip M. Robson (ORCID: https://orcid.org/0000-0002-4916-970X)
- Paul Kennedy (ORCID: https://orcid.org/0000-0003-4295-3670)
- Ketan Badani (ORCID: https://orcid.org/0000-0002-4778-3685)
Institutions
- Siemens (Germany) (DE)
- Mount Sinai Hospital (US)
- Siemens Healthineers (Germany) (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/jitc-2025-012833
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Georgia Clinical and Translational Science Alliance
- Bayer HealthCare
- National Center for Advancing Translational Sciences